
Sabine Brookman-May/X
Apr 28, 2025, 17:47
Sabine Brookman-May: Papillary disease HR NMIBC data from Sunrise1 presented by Félix Guerrero-Ramos
Sabine D. Brookman-May, Senior Vice President, Therapeutic Area Head Urologic Oncology at Aura Biosciences, shared on X:
“Papillary disease HR NMIBC data from Sunrise1 presented by Félix Guerrero-Ramos:
DFS rates at 6 and 9 months 85 and 81%
consistent rates in Ta + T1
Data from SR5 to be awaited to compare outcomes in %BCG experienced papillary NMIBC in a randomized phase 3″
More posts featuring Sabine Brookman-May on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 28, 2025, 17:40
Apr 28, 2025, 17:31
Apr 28, 2025, 17:07